LENVATOL 10 mg (LENVATINIB 10 mg)
| Active Ingredient | Lenvatinib |
|---|---|
| Manufacturers | Cipla Limited |
| Indications | Thyroid cancer |
| Strength | 10mg |
| Packaging | 10 Tablets in 1 Strip |
| Delivery Time | 6 To 15 days |
LENVATOL 10 mg contains Lenvatinib, a powerful targeted therapy medicine used to treat certain types of cancer, including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer). It works by inhibiting multiple tyrosine kinases that are responsible for the growth of cancer cells and the formation of blood vessels that supply tumors.
This oral medication is especially prescribed when cancer is advanced or has spread to other parts of the body. Lenvatol 10 mg helps slow or stop the progression of tumors and improves survival rates in patients who respond well to targeted therapy.
Medical Advice: Lenvatinib should only be used under strict medical supervision. Regular monitoring of liver function, blood pressure, and other vital signs is required during treatment.











There are no reviews yet.